Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Shareholder vote
confidence 98%
filed 2026-06-05
Item 5.07
This is a classic Item 5.07 disclosure of shareholder vote results from Xeris Biopharma's 2026 Annual Meeting held on June 4, 2026. The filing reports final voting tallies for three proposals: election of two Class II directors (Dawn Halkuff and John Johnson), ratification of Ernst & Young LLP as independent auditor, and advisory approval of named executive officer compensation. The detailed vote counts and quorum information are characteristic of mandatory shareholder meeting result disclosures.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-05
Item 5.07
This is a clear disclosure of shareholder vote results from TPG Inc.'s June 3, 2026 annual meeting of stockholders. The filing reports voting outcomes on four items: election of 13 directors, election of 9 Executive Committee members, advisory approval of executive compensation (say-on-pay), and ratification of Deloitte as independent auditor. Item 5.07 is the designated 8-K item for shareholder vote results, and the prose explicitly states "The matters voted on and the results of the votes cast" with detailed tabular voting data for each proposal.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-05
Item 5.07
This Item 5.07 disclosure reports the final voting results from Bridger Aerospace's June 4, 2026 Annual Meeting of Stockholders, including the election of three Class I directors (Dan Drohan, H. Wyman Howard III, and David Schellenberg) and ratification of Crowe LLP as independent auditor. The detailed vote tallies (votes for, against, withheld, and broker non-votes) are the core content required by Item 5.07, making this a textbook shareholder vote results disclosure that is material to investors' understanding of corporate governance.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-05
Item 5.07
This is a clear disclosure of shareholder vote results from Rubrik's June 3, 2026 Annual Meeting of Stockholders under Item 5.07. The filing reports the final voting tallies for three proposals: election of Class II directors (Asheem Chandna, Ravi Mhatre, and Arvind Nithrakashyap), ratification of KPMG LLP as independent auditor, and advisory approval of annual say-on-pay votes. The detailed vote counts and board determination to conduct annual compensation votes are material to investors assessing corporate governance and director accountability.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-05
Item 5.07
This Item 5.07 disclosure reports the results of Sinclair's annual stockholder meeting held on June 4, 2026, including voting outcomes for three proposals: election of nine directors, ratification of PricewaterhouseCoopers LLP as independent auditors, and a non-binding advisory vote on executive compensation. The filing presents detailed vote tallies (For/Against/Abstain/Broker Non-Votes) for each proposal, which is the core content of shareholder_vote_results disclosures.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-05
Item 5.07
This is a clear disclosure of shareholder voting results from the 2026 Annual Meeting held on June 4, 2026, reporting the election of ten directors and ratification of Deloitte & Touche LLP as independent auditor. The filing presents detailed vote tallies for each director nominee and the auditor ratification proposal, which is the core content of Item 5.07 disclosures. The results are material to investors as they confirm the composition of the Board and auditor selection.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-04
Item 5.07
This is a classic Item 5.07 disclosure of shareholder vote results from the 2026 Annual Meeting of Stockholders. The filing reports voting outcomes on three proposals: election of nine directors, advisory approval of named executive officer compensation, and ratification of Ernst & Young LLP as independent auditors. All three proposals passed with substantial majorities, and the disclosure includes detailed vote tallies (For, Against, Abstaining, Broker Non-Votes) for each director nominee and proposal, which is the standard format for shareholder meeting results.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-04
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of Arrow Financial's 2026 Annual Meeting of Shareholders held on June 3, 2026. The filing presents voting tabulations for three matters: election of four Class A directors, advisory approval of 2025 executive compensation, and ratification of Crowe LLP as independent auditor. All three proposals passed with substantial majorities, making this a material shareholder vote results disclosure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-04
Item 5.07
This is a clear disclosure of shareholder vote results from the June 2, 2026 annual meeting, covering four matters: election of twelve directors, ratification of auditors (Deloitte and Touche LLP), advisory vote on executive compensation, and approval of an amendment to the 2024 Omnibus Incentive Plan. The filing presents voting tallies (For, Against, Abstain, Broker Non-Votes) for each matter, which is the hallmark of Item 5.07 disclosure and directly matches the shareholder_vote_results event type.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-04
Item 5.07
Patterson-UTI Energy held its Annual Meeting of Stockholders on June 4, 2026, with shareholders voting on four matters: election of ten directors, ratification of PricewaterhouseCoopers LLP as independent auditor, approval of an amendment to the 2021 Long-Term Incentive Plan increasing available shares by 28.9 million, and an advisory vote on named executive officer compensation. All proposals passed with detailed vote tallies disclosed.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-04
Item 5.07
VAALCO Energy held its Annual Meeting of Stockholders on June 4, 2026, and stockholders approved all four proposals: election of five directors, ratification of KPMG LLP as auditor, advisory approval of named executive officer compensation, and approval of Amendment No. 3 to the 2020 Long Term Incentive Plan.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-04
Item 5.07
This is a classic Item 5.07 disclosure of shareholder vote results from the 2026 Annual Meeting held on June 4, 2026. The filing reports final voting tallies for three proposals: election of 9 directors, advisory approval of named executive officer compensation, and ratification of PwC as independent auditor. All three proposals passed with substantial majorities, making this a material disclosure of shareholder meeting outcomes.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-04
Item 5.07
Myriad Genetics held its Annual Meeting of Stockholders on June 4, 2026, with stockholders voting on five proposals: election of three Class III directors (Paul M. Bisaro, Rashmi Kumar, and Lee N. Newcomer, M.D.), ratification of Ernst & Young LLP as independent auditor, advisory approval of named executive officer compensation, approval of an amendment to the 2012 Employee Stock Purchase Plan increasing authorized shares by 4,000,000, and approval of the new 2026 Employee, Director and Consultant Equity Incentive Plan with 8,463,567 shares available for issuance. All five proposals passed with detailed vote tallies disclosed.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-04
Item 5.07
This 8-K Item 5.07 discloses the final voting results from Abercrombie & Fitch's Annual Meeting of Stockholders held on June 3, 2026, covering three proposals: election of nine directors, advisory approval of named executive officer compensation ("Say on Pay"), and ratification of PricewaterhouseCoopers LLP as independent auditor. The filing presents detailed vote tallies (For, Against, Abstentions, Broker Non-Votes) for each proposal, confirming all three matters were approved. This is a textbook shareholder_vote_results disclosure required under Item 5.07.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-04
Item 5.07
This is a clear Item 5.07 disclosure of shareholder vote results from Fresh Del Monte's June 4, 2026 Annual General Meeting. The filing reports voting outcomes on four proposals: election of two directors (Michael J. Berthelot and Lori Tauber Marcus), ratification of Ernst & Young LLP as auditor, advisory vote on named executive officer compensation, and approval of amended articles of association. All proposals passed with substantial majorities, making this a routine but material shareholder governance disclosure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-04
Item 5.07
This Item 5.07 discloses the results of Medicus Pharma's 2026 Annual General and Special Meeting of Shareholders held on June 3, 2026, including voting outcomes on three proposals: ratification of KPMG LLP as auditor, election of nine directors, and approval of a special resolution authorizing share consolidation up to a 50:1 ratio. The disclosure is a direct and complete reporting of shareholder voting results as required by Item 5.07.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-04
Item 5.07
Coronado Global Resources held its Annual General Meeting on June 3-4, 2026, with shareholders voting on six proposals: election of six directors, advisory approval of named executive officer compensation, frequency of future compensation votes (approved for every three years), ratification of Ernst & Young as independent auditor, and approval of up to 90 million securities under the 2018 Equity Incentive Plan. All proposals passed with substantial majorities.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-04
Item 5.07
This is a clear disclosure of shareholder vote results from Aclaris Therapeutics' 2026 annual meeting held on June 4, 2026. The filing reports voting outcomes for three proposals: election of two directors (Anand Mehra, M.D. and Maxine Gowen, Ph.D.), advisory approval of named executive officer compensation, and ratification of PricewaterhouseCoopers LLP as independent auditor. The detailed vote tallies (For, Against, Withheld, Abstained, and Broker Non-Votes) are characteristic of Item 5.07 shareholder vote results disclosures.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-04
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of MFA Financial's 2026 Annual Meeting of Stockholders held on June 3, 2026. The filing presents voting tallies for three proposals: election of two Class I directors (Laurie S. Goodman and Richard C. Wald), ratification of KPMG LLP as independent auditor, and advisory approval of executive compensation. All three proposals passed with clear majorities. Shareholder vote results are material to investors as they confirm governance outcomes and director/auditor continuity.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-04
Item 5.07
This is a clear disclosure of shareholder vote results from PennyMac's June 3, 2026 Annual Meeting of Stockholders. The filing presents voting outcomes for three proposals: election of ten directors, ratification of Deloitte & Touche LLP as independent auditor, and non-binding approval of executive compensation. All three proposals passed with substantial majorities, and the detailed vote tallies (votes for, against, abstentions, and broker non-votes) are characteristic of Item 5.07 shareholder vote result disclosures.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-04
Item 5.07
W&T Offshore held its Annual Meeting of Shareholders and disclosed voting results on six proposals: election of six directors, advisory approval of named executive officer compensation, ratification of Deloitte & Touche LLP as independent auditors, and approval of an amendment to the 2023 Incentive Compensation Plan increasing authorized shares from 10,000,000 to 22,000,000.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-04
Item 5.07
This Item 5.07 disclosure presents the complete results of Antero Midstream's June 3, 2026 annual stockholder meeting, including voting tallies for director elections (Peter A. Dea, W. Howard Keenan Jr., Janine J. McArdle), ratification of KPMG LLP as auditor, advisory approval of named executive officer compensation, and frequency of future advisory compensation votes. The detailed vote counts and outcomes are the core content of a shareholder vote results disclosure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-04
Item 5.07
This is a clear disclosure of shareholder vote results from Antero Resources' June 3, 2026 annual meeting, covering three proposals: election of Class I directors (Brenda R. Schroer and Thomas B. Tyree, Jr.), ratification of KPMG LLP as independent auditor, and advisory approval of named executive officer compensation. The filing presents detailed voting tallies (For, Against, Abstain, Broker Non-Votes) for each proposal, which is the hallmark of Item 5.07 disclosure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-04
Item 5.07
This Item 5.07 filing discloses the final voting results from Scholar Rock's June 4, 2026 annual meeting of stockholders, covering three proposals: election of Class II directors, ratification of Deloitte & Touche LLP as independent auditor, and advisory approval of named executive officer compensation. The disclosure presents vote tallies for each proposal, which is the core content of a shareholder vote results disclosure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-04
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of Pulmonx's 2026 Annual Meeting of Stockholders held on June 4, 2026. The filing presents voting outcomes for three proposals: election of three Class III directors (Thomas W. Burns, Georgia Garinois-Melenikiotou, and Dana G. Mead, Jr.), ratification of BDO USA, P.C. as independent auditor, and a non-binding advisory vote on executive compensation. All three proposals passed with substantial majorities. Shareholder vote results are material to investors as they confirm governance and audit oversight decisions.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-04
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of SolarEdge's annual meeting of stockholders held on June 3, 2026. The filing presents voting results for four proposals: election of seven directors, ratification of auditors (Kost Forer Gabbay & Kasierer), advisory approval of named executive officer compensation, and an amendment to the Certificate of Incorporation. The detailed vote tallies (For, Against, Abstain, Broker Non-Votes) for each proposal are the core content, making this unambiguously a shareholder vote results disclosure. The material nature is confirmed by the inclusion of director elections and executive compensation approval, both of which affect investor assessment of governance and management.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-04
Item 5.07
This is a classic Item 5.07 disclosure of shareholder vote results from Loar Holdings' June 2, 2026 Annual Meeting of Shareholders. The filing reports voting outcomes on four proposals: election of three directors (Raja Bobbili, Alison Bomberg, and Margaret McGetrick), ratification of Ernst & Young LLP as independent auditor, advisory approval of named executive officer compensation, and frequency of future advisory votes on compensation. All proposals passed with substantial majorities. This is material as it documents the formal governance actions taken at the annual meeting.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-04
Item 5.07
This is a clear disclosure of shareholder vote results from the 2026 Annual Meeting held on June 4, 2026, including tabulated votes for the election of four directors (David Ayoub, William Barclay, James Dowd, and John Sharkey) and ratification of Bonadio & Company, LLP as independent auditor. The detailed vote tallies and Item 5.07 designation are unmistakable indicators of shareholder voting outcomes.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-04
Item 5.07
This Item 5.07 discloses the certified results of shareholder votes at the June 3, 2026 annual meeting, including the election of two Class II directors (Timothy M. Lamothe and Isolde G. O'Hanlon) and ratification of Grant Thornton LLP as independent auditor. The filing presents vote tallies for each proposal, which is the core content of shareholder_vote_results disclosures.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-04
Item 5.07
This is a clear disclosure of shareholder vote results from Heritage Global Inc.'s 2026 Annual Meeting of Shareholders held on June 3, 2026. The filing reports voting outcomes for two proposals: (1) election of Michael Hexner and William Burnham as Class II directors, with specific vote tallies (For, Withheld, Broker Non-Votes), and (2) ratification of UHY LLP as independent auditor for fiscal year 2026, with detailed vote counts. This directly matches the shareholder_vote_results event type, which covers results of votes at annual or special meetings of security holders (Item 5.07).
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-04
Item 5.07
This 8-K Item 5.07 discloses the final voting results from CarGurus' June 3, 2026 annual meeting of stockholders, covering three proposals: election of Class III directors (Manik Gupta and Langley Steinert), ratification of Ernst & Young LLP as independent auditors, and a non-binding advisory vote on named executive officer compensation. The disclosure of shareholder vote outcomes is the core material event required under Item 5.07.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-04
Item 5.07
Stockholders voted on five proposals at the June 3, 2026 Annual Meeting: election of Michael Heffernan as a Class I director, ratification of Ernst & Young LLP as auditor, advisory approval of named executive officer compensation, approval of the Amended and Restated 2019 Stock Incentive Plan increasing available shares by 8,000,000, and approval of an amendment to increase authorized common shares from 200 million to 400 million. All proposals passed with detailed vote tallies disclosed.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-04
Item 5.07
This is a clear disclosure of shareholder voting results from OneSpaWorld's June 3, 2026 Annual Meeting of Shareholders. The filing reports voting outcomes for four proposals: election of seven directors, advisory vote on named executive officer compensation, approval of an amended equity incentive plan, and ratification of Ernst & Young LLP as independent auditor. The detailed vote tallies (For/Against/Abstain/Broker non-votes) for each proposal are the hallmark of Item 5.07 disclosures and constitute material information about shareholder governance actions.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-04
Item 5.07
Kura Oncology held its Annual Meeting of Stockholders on June 4, 2026, with shareholders voting on six proposals including director elections, auditor ratification, Say-on-Pay advisory vote, Say-on-Pay frequency, and approval of amendments to the 2014 Equity Incentive Plan and ESPP.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-04
Item 5.07
Minerva Neurosciences held its 2026 Annual Meeting of Stockholders on June 3, 2026, with shareholders voting on six proposals including director elections, charter amendments, advisory compensation votes, and auditor ratification. All proposals were approved by stockholders.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-04
Item 5.07
This is a clear disclosure of shareholder voting results from Funko's Annual Meeting of Stockholders held on June 3, 2026. The filing reports the outcomes of three proposals: election of three Class III directors (Diane Irvine, Jesse Jacobs, and Sarah Kirshbaum Levy), ratification of PricewaterhouseCoopers LLP as independent auditor, and advisory approval of named executive officer compensation. All three items passed. This is a quintessential Item 5.07 disclosure and is material to investors as it documents the composition of the board and auditor ratification.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-04
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of Kalaris Therapeutics' 2026 Annual Meeting of Stockholders held on June 3, 2026. The filing presents voting results for four matters: election of three Class III directors (Napoleone Ferrara, David Hallal, and Leone Patterson), advisory approval of named executive officer compensation, recommendation on frequency of future advisory compensation votes (approved for annual frequency), and ratification of Deloitte & Touche LLP as independent auditor. All votes passed with substantial majorities, making this a material shareholder vote results disclosure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-04
Item 5.07
This is a clear disclosure of shareholder voting results from Amylyx Pharmaceuticals' Annual Meeting of Stockholders held on June 4, 2026. The filing reports the final vote tallies for three proposals: election of Class II directors (George Mclean Milne Jr., Ph.D. and Paul Fonteyne), ratification of Deloitte & Touche LLP as independent auditor, and advisory approval of named executive officer compensation. This is a textbook Item 5.07 shareholder vote results disclosure, material to investors as it reflects stockholder decisions on governance and audit matters.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-04
Item 5.07
This Item 5.07 disclosure reports the results of Stoke Therapeutics' 2026 Annual Meeting of Stockholders held on June 3, 2026, including voting outcomes for three proposals: election of three Class I directors (G. Clare Kahn, Adrian Krainer, and Julie Anne Smith), ratification of Ernst & Young LLP as independent auditor, and advisory approval of named executive officer compensation. The filing presents vote tallies (Shares For, Against, Withheld, and Broker Non-Votes) for each proposal, which is the standard format for shareholder vote result disclosures under Item 5.07.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-04
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of Tenax Therapeutics' 2026 annual meeting of stockholders held on June 2, 2026. The filing presents voting results for two proposals: (1) election of seven directors to one-year terms, with vote tallies for each nominee (For/Withheld/Broker Non-Votes), and (2) ratification of Cherry Bekaert LLP as independent auditor. The disclosure is material as it documents the outcome of shareholder governance actions and confirms the composition of the board and auditor selection.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-04
Item 5.07
CV Sciences held its 2026 Annual Meeting on June 2, 2026, with shareholders voting on three proposals: election of three directors (passed), authorization of a reverse stock split (failed), and ratification of Haskell & White LLP as independent auditor (passed). The filing reports final voting tallies including vote counts, percentages, and broker non-votes.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-04
Item 5.07
This is a clear disclosure of shareholder vote results from the 2026 annual meeting held on June 2, 2026, covering three matters: election of nine directors, ratification of Deloitte & Touche LLP as independent auditor, and advisory approval of executive compensation. The filing presents vote tallies (for, against, withheld, abstain, broker non-votes) for each matter, which is the standard format for Item 5.07 shareholder vote results disclosures.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-04
Item 5.07
OnKure held its Annual Meeting of Stockholders on June 3, 2026, with shareholders voting on three proposals: election of Class II directors (Carruthers, Jansen, Mathers), ratification of KPMG LLP as independent auditor, and approval of the Amended and Restated 2024 Equity Incentive Plan. Vote results for all three proposals are disclosed with detailed tallies.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-04
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of MasterBrand's Annual Meeting of Shareholders held on June 4, 2026. The filing presents voting results for three proposals: election of three directors (Ann Fritz Hackett, R. David Banyard, Jr., and Philip Fracassa), advisory approval of 2025 NEO compensation, and ratification of PricewaterhouseCoopers LLP as independent auditor. All three proposals passed with substantial majorities. Shareholder vote results are material to investors as they reflect governance outcomes and stakeholder approval of key corporate matters.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-04
Item 5.07
This is a clear disclosure of shareholder vote results from Royalty Pharma's 2026 Annual General Meeting held on June 4, 2026. The filing presents detailed vote tabulations for all 10 proposals submitted to shareholders, including director elections, executive compensation approval, auditor ratification, and share authorization matters. Item 5.07 is the designated 8-K item for shareholder vote results, and the prose directly reports the inspector of election's certified vote counts for each proposal.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-04
Item 5.07
Sarepta held its Annual Meeting of Stockholders on June 4, 2026, with stockholders voting on five proposals: election of five Class I directors (Douglas S. Ingram, Hans Wigzell, Kathryn J. Boor, Michael Chambers, and Deirdre Connelly), advisory approval of named executive officer compensation, approval of the 2026 Equity Incentive Plan, approval of the 2026 Employee Stock Purchase Plan, and ratification of KPMG as independent auditor. All proposals passed with substantial majorities.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-04
Item 5.07
Kaiser Aluminum held its 2026 Annual Meeting of Stockholders, with results including election of three Class I directors (Hoffman, Minor, Wilcox), advisory approval of named executive officer compensation (98.68% for), ratification of Deloitte & Touche LLP as independent auditor (98.20% for), and approval of the Amended 2021 Equity and Incentive Compensation Plan increasing available shares by 395,000 (94.43% for).
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-04
Item 5.07
CRISPR Therapeutics held its Annual Meeting on June 4, 2026, and disclosed the final voting results for 13 proposals, including approval of financial statements, board re-elections, compensation approvals, capital increases, and auditor re-elections, with detailed tabulation of votes cast for each proposal.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-04
Item 5.07
This is a clear Item 5.07 disclosure of shareholder vote results from LifeStance Health Group's June 2, 2026 annual meeting. The filing reports voting outcomes for three proposals: election of directors (Proposal 1), ratification of PricewaterhouseCoopers LLP as independent auditor (Proposal 2), and advisory vote on named executive officer compensation (Proposal 3), with detailed vote tallies for each. This is a material disclosure as it documents stockholder approval of key governance matters including board composition and auditor selection.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-04
Item 5.07
This is a Form 8-K Item 5.07 disclosure of shareholder meeting results. The filing reports the final voting outcomes for three proposals at the June 4, 2026 annual meeting: election of two Class II directors (Malte Peters, M.D. and Mace Rothenberg, M.D.), ratification of PricewaterhouseCoopers, LLP as independent auditor, and advisory approval of named executive officer compensation. The disclosure includes vote tallies, quorum confirmation (90.96% attendance), and context regarding a prior director resignation. This is a material event as it reflects stockholder decisions on board composition and corporate governance matters.
View raw filing on EDGAR →